Response to Madhivanan et al.

Sexually Transmitted Diseases

Volumn 40, Issue 6, 2013, Pages 518-519

  Mehta, Supriya D ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LETTER; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUALITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VAGINITIS; WORLD HEALTH ORGANIZATION;

ANTI-INFECTIVE AGENTS, LOCAL; CIRCUMCISION, MALE; FEMALE; HUMANS; MALE; PENIS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; VAGINOSIS, BACTERIAL;

EID: 84878864366     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318295daea     Document Type: Letter

References (20)

1. Madhivanan P, Baretteo GA, Revawala A, et al. Where are we with partner treatment in bacterial vaginosis? A critical appraisal of the latest s-stematic review. Sex Transm Dis 2013; 40:518.
2. Mehta SD. Systematic review of randomized trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women. Sex Transm Dis 2012; 39:822-830.
3. Swedberg J, Steiner J, Deiss F, et al. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA 1985; 254: 1046-1049.
4. Vejtorp M, Bollerup A, Vejtorp L, et al. Bacterial vaginosis: A double blind randomized trial of the effect of treatment of the sexual partner. Br J Obstetr Gynaecol 1988; 95:920-926.
5. Mengel M, Berg A, Weaver C, et al, and the Bacterial Vaginosis Study Group. The effectiveness of single-dose therapy for patients and their partners with bacterial vaginosis. J Fam Pract 1989; 28:163-171.
6. Moi H, Erkkola R, Jerve F, et al. Should male consorts of women with bacterial vaginosis be treated? GenitourinMed 1989; 65:263-268.
7. Vutyavanich T, Pongsuthirak P, Vannareumol P, et al. A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstet Gynecol 1993; 82:550-554.
8. Colli E, Landoni M, Parazzini F, et al. Treatment of male partners and recurrence of bacterial vaginosis: A randomised trial. Genitourin Med 1997; 73:267-270.
9. Centers for Disease Control and Prevention, 2010. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 73: (RR-12):1-110.
10. World Health Organization (WHO). Guidelines for the management of sexuall-transmitted infections. Geneva: WHO; 2003. Retrieved October 3, 2011 from: http://www.who.int/hiv/topics/vct/sw-toolkit/guidelines-management-sti. pdf.
11. Potter J. Should sexual partners of women with bacterial vaginosis receive treatment? Br J Gen Pract 1999; 49:913-918.
12. Larsson P-G, Brandsborg E, Forsum U, et al. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis 2011; 11:223.
13. Eschenbach DA, Critchlow CW,Watkins H, et al. A dose-duration study of metronidazole for the treatment of nonspecific vaginosis. Scand J Infect Dis 1983; 40:73-80.
14. Hagstrom B, Lindsted J. Comparison of two different regimens of metronidazole in the treatment of non-specific vaginitis. Scand J Infect Dis 1983; 40:95-96.
15. HLvik P. Nonspecific vaginitis in an outpatient clinic. Comparison of three dosage regimens of metronidazole. Scand J Infect Dis 1983; 40:107-110.
16. Jerve F, Berdal TB, Bohman P, et al. Metronidazole in the treatment of nonspecific vaginitis (NSV). Br J Vener Dis 1984; 60:171-174.
17. Stewart LA. Chemotherapy in adult highgrade glioma: A systematic review and metaanalysis of individual patient data from 12 randomized trials. Lancet 2002; 359: 1011-1018.
18. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27:1218-1224.
19. Hodnett ED. Pain and women's satisfaction with the experience of childbirth: A systematic review. Am J Obstet Gynecol 2002; 186:S160-S172.
20. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research. JAMA 2005; 294:218-228.